Researchers at UNIGE and HUG have created CAR-T cells that can selectively target malignant gliomas, sparing the surrounding healthy tissue. Glioblastoma is the most common and aggressive form of ...

Researchers at the University of Geneva developed CAR T cells targeting the glioblastoma marker PTPRZ1, showing efficacy ...

Researchers have developed a promising CAR-T cell therapy targeting glioblastoma, the most aggressive brain tumor.

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective.

Glioblastoma is the most common and most aggressive primary brain tumour, with an average survival after diagnosis of less ...

Researchers at RIKEN in Japan have developed technology that can alter, within the body, the recognized identity of proteins, which allowed researchers to target mouse tumors with a protein and then ...

has succeeded in identifying a specific marker on the surface of tumour cells, and in generating immune cells carrying an ...

A high density of tumor-associated macrophages (TAMs) is associated with poorer prognosis and survival in breast cancer patients. Recent studies have shown that lipid accumulation in TAMs can promote ...

Doctors have long known that children who become seriously ill with certain respiratory viruses such as respiratory syncytial ...

A century after scientists suspected it existed, researchers have uncovered a new type of cell with almost magical abilities ...

Amazon Trust me, it won't look weird! Just remember to account for that ... www.amazon.com, www.amazon.com Promising review: "Impressed with the size of the cell which provides a larger surface area ...